RJ9-32066-99074
3 vaccinations
5 coded responses
36 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 232 / VA
- Registered
- 2022-07-18
- Relationship
- Child or adolescent in my care
- Guardian
- U95-17971-02361
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-18
Registered in v-safe
-
2022-07-18
Dose 1 — Pfizer-BioNTech
- 2022-07-18
- 2022-07-19
- 2022-07-20
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-08-01
-
2022-08-08
Dose 2 — Pfizer-BioNTech
- 2022-08-08
-
2022-08-09
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Irritability/crying, DiarrheaUnder 3 check-in
- 2022-08-10
- 2022-08-12
- 2022-08-13
- 2022-08-14
- 2022-08-15
- 2022-08-22
- 2022-08-29
- 2022-09-05
- 2022-09-12
- 2022-09-19
-
2022-10-06
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-06
-
2022-10-07
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-10-08
- 2022-10-09
- 2022-10-10
-
2022-10-11
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: Fair · Irritability/crying · Be unable to do your normal daily activitiesFree text: Congestion/cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-12
Survey response — days 1–6 daily, dose 3, under 3MedDRA: Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Irritability/cryingFree text: Cold symptoms, runny nose congestion!MedDRA releases: 2024-11 · check-in free text available
-
2022-10-13
Survey response — day 7, dose 3, under 3MedDRA: Respiratory tract congestion — Feeling: GoodFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-20
Survey response — day 14, dose 3, under 3MedDRA: Cough, Respiratory tract congestion, Respiratory tract infection viral, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Congestion, cough, runny nose. Appears to be respiratory virus.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-27
- 2022-11-03
- 2022-11-10
- 2022-11-17
-
2023-01-05
Survey response — 3 months, dose 3, under 3MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-18 | Pfizer-BioNTech | No |
| 2 | 2022-08-08 | Pfizer-BioNTech | No |
| 3 | 2022-10-06 | Pfizer-BioNTech | Flu |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 3, under 3
Systemic reaction (other): Congestion/cold symptoms
Systemic reaction (other): Cold symptoms, runny nose congestion!
Release 12 (Under 3) — day 7, dose 3, under 3
Systemic reaction (other): Congestion
Release 12 (Under 3) — day 14, dose 3, under 3
Symptoms: Congestion, cough, runny nose. Appears to be respiratory virus.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Respiratory tract infection viral | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release